CAS: 143653-53-6 - Abciximab
Formula:Unspecified
- Synonyms:
- Immunoglobulin G1, anti-(human integrin αIIbβ3) Fab fragment (human-mouse monoclonal c7E3 clone p7E3VHhCγ1 γ1-chain), disulfide with human-mouse monoclonal c7E3 clone p7E3VκhCκ κ-chain
- Immunoglobulin G1, (human-mouse monoclonal c7E3 clone p7E3VHhCγ1 Fab fragment anti-human glycoprotein IIb/IIIa receptor), disulfide with human-mouse monoclonal c7E3 clone p7E3VκhCκ light chain
- Abciximab
- CentoRx
- C 7E3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Abciximab REF: TM-T76844CAS: 143653-53-6 | SDS-PAGE:95.2%;SEC-HPLC:95.9% | 198.00 €~2,255.00 € | Tue 17 Dec 24 |
 | Abciximab REF: 3D-CLA1118CAS: 143653-53-6 | - - - | To inquire | Fri 27 Dec 24 |
Abciximab
CAS:143653-53-6
Abciximab: chimeric antibody, anti-platelet, blocks glycoprotein IIb/IIIa, vitronectin, Mac-1.
Purity:
SDS-PAGE:95.2%;SEC-HPLC:95.9%
Color and Shape:
Liquid
Molecular weight:
95.18 kDa
Ref: TM-T76844
| 1mg | 198.00 € | ||
| 5mg | 523.00 € | ||
| 10mg | 823.00 € | ||
| 25mg | 1,234.00 € | ||
| 50mg | 1,652.00 € | ||
| 100mg | 2,255.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Ref: 3D-CLA1118
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
